SH3BGR Antikörper (N-Term)
-
- Target Alle SH3BGR Produkte
- SH3BGR (SH3 Domain Binding Glutamic Acid-Rich Protein (SH3BGR))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SH3BGR Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- SH3 BGR antibody was raised against the N terminal of SH3 GR
- Aufreinigung
- Affinity purified
- Immunogen
- SH3 BGR antibody was raised using the N terminal of SH3 GR corresponding to a region with amino acids CGDFDSFFSAKEENIIYSFLGLAPPPDSKGSEKAEEGGETEAQKEGSEDV
-
-
- Applikationshinweise
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
SH3BGR Blocking Peptide, catalog no. 33R-1691, is also available for use as a blocking control in assays to test for specificity of this SH3BGR antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SH0 GR antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- SH3BGR (SH3 Domain Binding Glutamic Acid-Rich Protein (SH3BGR))
- Andere Bezeichnung
- SH3BGR (SH3BGR Produkte)
- Synonyme
- 21-garp antikoerper, MGC82574 antikoerper, Sh3bgr antikoerper, ACYPI008600 antikoerper, RGD1563599 antikoerper, 21-GARP antikoerper, 5430437A18Rik antikoerper, SH3 domain binding glutamate-rich protein L homeolog antikoerper, SH3 domain binding glutamic acid-rich protein antikoerper, SH3 domain binding glutamate-rich protein antikoerper, SH3 domain binding glutamate rich protein antikoerper, SH3-binding domain glutamic acid-rich protein antikoerper, sh3bgr.L antikoerper, Sh3bgr antikoerper, SH3BGR antikoerper
- Hintergrund
- SH3BGR gene maps to the DS-CHD region and is a potential candidate for the pathogenesis of CHD.
- Molekulargewicht
- 26 kDa (MW of target protein)
-